NCT05892887

Brief Summary

The analgesic efficacy of different volumes in ESPB patients undergoing single-level lumbar spine fixation

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Jun 2023

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 10, 2023

Completed
22 days until next milestone

Study Start

First participant enrolled

June 1, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 7, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 20, 2023

Completed
Last Updated

October 10, 2023

Status Verified

October 1, 2023

Enrollment Period

4 months

First QC Date

May 10, 2023

Last Update Submit

October 8, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Total morphine consumption

    Patients were allowed to receive incremental doses of morphine 3mg intravenously if numerical rating scale pain score will be ≥ then the total amount of morphine will be recorded

    First 24 hours postoperatively

Secondary Outcomes (4)

  • Numerical rating scale

    Up to 48 hours postoperatively

  • Time to the first rescue analgesic

    Up to 24 hours postoperatively

  • Postoperative complications

    Up to 24 hours postoperatively

  • 5-point scale

    Up to 24 hours postoperative

Study Arms (3)

Erector 10

EXPERIMENTAL

Received 10ml of preoperative bilateral ultrasound guided ESPB by bupivacaine 0.25% on each side

Drug: Bupivacaine 0.25% Injectable Solution

Erector 15

EXPERIMENTAL

Received 15ml of preoperative bilateral ultrasound guided ESPB by bupivacaine 0.25% on each side

Drug: Bupivacaine 0.25% Injectable Solution

Erector 20

EXPERIMENTAL

Received 20ml of preoperative bilateral ultrasound guided ESPB by bupivacaine 0.25% on each side

Drug: Bupivacaine 0.25% Injectable Solution

Interventions

Bilateral ultrasound guided in erector spinae plane block by bupivacaine 0.25%

Erector 10Erector 15Erector 20

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18-65 years.
  • Both genders.
  • American Society of Anesthesiologists' (ASA) physical status I or II.
  • Undergoing single level lumbar spine fixation.

You may not qualify if:

  • Patient refusal.
  • Pregnant females.
  • Renal, lung, heart, or liver disorders.
  • Communication difficulties which might prevent a reliable postoperative assessment.
  • Contraindication to regional anesthesia (bleeding disorder, use of any anticoagulants, local infection, known allergy to local anesthetics).
  • BMI more than 30 kg/m2.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kafrelsheikh University

Kafr ash Shaykh, Kafrelsheikh, 33516, Egypt

Location

Related Publications (1)

  • Algyar MF, Zahra AA, Elshikhali AS, Abdelhameed EA, El Hefny DA, Moharam SA, ElSharkawy MS, Farghaly OS, Ahmed MA. Analgesic efficacy of different volumes in erector spinae plane block in patients undergoing single level lumbar spine fixation: a non-inferiority randomized trial. BMC Anesthesiol. 2025 Sep 1;25(1):439. doi: 10.1186/s12871-025-03247-z.

MeSH Terms

Conditions

Agnosia

Interventions

Bupivacaine

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Kafrelsheikh University, Kafrelsheikh, Egypt

Study Record Dates

First Submitted

May 10, 2023

First Posted

June 7, 2023

Study Start

June 1, 2023

Primary Completion

September 20, 2023

Study Completion

September 20, 2023

Last Updated

October 10, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will share

The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Shared Documents
STUDY PROTOCOL
Time Frame
The data will be available after the end of study for one year.
Access Criteria
The data will be available upon a reasonable request from the corresponding author.

Locations